Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

NCT00193193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Paclitaxel
DRUG: Estramustine
DRUG: Carboplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]